penetrant LYN/BTK dual inhibitor, in B-cell non-Hodgkin lymphoma (B-NHL). The data were presented at the 66th American Society of Hematology (ASH) Annual Meeting. The analysis pooled data from ongoing ...

Significant tumor response was also observed in other B-NHL, including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone B-cell lymphoma ...